By Steven Reinberg HealthDay Reporter MONDAY, April 16 (HealthDay News) -- An experimental pill reduced the number of lesions in the brains of people with multiple sclerosis (MS), researchers report. The drug, which currently goes by the name ONO-4641, "actually caused a ...

According to federal health regulators more information needs to be added to labels on a popular class of birth control pills that includes Bayer AG's Yaz and Yasmin, to show they may raise the risk of blood clots. A clot in blood vessels can prove fatal if it breaks loose ...

The drug was rejected in a 10-6 vote the first time it came before a Food and Drug Administration (FDA) advisory panel, in 2010, due to safety concerns. However when the medication returned for another review in February, the advisory committee gave it near-unanimous approval (20-2). Because the FDA often ...

Biologist Jon Amberg has spent the last two years obsessed with fish guts, laboring over a singular challenge: Develop a poison pill that will kill Asian carp and leave other fish unscathed.

Individuals with major depressive disorder (MDD) often undergo multiple courses of antidepressant treatment during their lives. This is because the disorder can recur despite treatment and because finding the right medication for a specific individual can take time.

By Jenifer Goodwin HealthDay Reporter MONDAY, March 26 (HealthDay News) -- Nearly one in five U.S. pharmacies gave out misinformation to researchers posing as 17-year-old girls seeking emergency contraception, often saying that it was "impossible" for girls to get the pill, a new ...

CHICAGO -- A novel oral anti-coagulant outperformed the injected standard therapy on important safety measures for initial and long-term treatment of pulmonary embolism a blockage of lung blood vessels usually caused by a clot and showed comparable efficacy, according to data from the EINSTEIN-PE trial presented today at ...

The National Institute for Health and Clinical Excellence (Nice) issued new draft guidance recommending fingolimod (brand name Gilenya) on the NHS for some patients with a form of MS. The new drug can help reduce the number of relapses in adults with highly active relapsing-remitting multiple sclerosis (RRMS), which is ...

Teva Pharmaceutical Industries Ltd. Has won U.S. approval to sell the first generic version of Lexapro for depression and anxiety. Teva has been granted a 180-day exclusivity, so no other firm can market the generic medication in the United States in that timeframe, the Food and Drug Administration (FDA) said ...

By Serena Gordon HealthDay Reporter WEDNESDAY, March 14 (HealthDay News) -- Yet another orally taken medication shows some promise in preventing relapse and disability for people with relapsing-remitting multiple sclerosis, a new report suggests. In the new study, laquinimod reduced the annual ...

A life-extending pill for advanced melanoma that The Institute of Cancer Research (ICR) and The Royal Marsden Hospital helped develop is now available in the UK.

(AP) -- A panel of advisers to the Food and Drug Administration overwhelmingly backed approval for a highly anticipated anti-obesity pill from Vivus Inc., a drug which the FDA previously rejected due to safety concerns.